Angiotensin II-dependent induction of AT2 receptor expression after renal ablation

American Journal of Physiology - Renal Physiology

Volumn 288, Issue 1 57-1, 2005, Pages

  Vázquez, Erika ^a   Coronel, Israel ^a   Bautista, Rocio ^b   Romo, Eunice ^a   Villalón, Carlos M ^a   Avila Casado, M Carmen ^c   Soto, Virgilia ^c   Escalante, Bruno ^a,d  

^a INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

^d DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

AT1 receptor; Losartan; PD 123319; Renovascular hypertension

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOSARTAN; MESSENGER RNA; RAMIPRIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CATHETER ABLATION; CONTROLLED STUDY; DRUG EFFECT; GENE EXPRESSION; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; KIDNEY INJURY; KIDNEY PARENCHYMA; MALE; NONHUMAN; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RAT; RECEPTOR BLOCKING; RECEPTOR GENE; RECEPTOR UPREGULATION; RENOVASCULAR HYPERTENSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCLEROSIS; URINARY EXCRETION;

EID: 11144257715     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00216.2004     Document Type: Article

References (22)

1. Bautista R, Sanchez A, Hernandez J, Oyekan A, and Escalante B. Angiotensin II type AT (2) receptor mRNA expression and renal vasodilatation are increased in renal failure. Hypertension 38: 669-673, 2001.
2. Cao Z, Bonnet F, Candido R, Nesteroff SP, Burns WC, Kawachi H, Shimizu F, Carey RM, DeGasparo M, and Cooper ME. Angiotensin type 2 receptor antagonism confers renal protection in a rat model of progressive renal injury. J Am Soc Nephrol 13: 1773-1787, 2003.
3. 2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism. Hypertension 31: 349-355, 1998.
4. Guan S, Fox J, Mitchell KD, and Navar LG. Angiotensin and angiotensin converting enzyme tissue levels in two-kidney, one clip hypertensive rats. Hypertension 20: 763-767, 1992.
5. Hernandez J, Astudillo H, and Escalante B. Angiotensin II stimulates cyclooxygenase-2 mRNA expression in renal tissue from rats with kidney failure. Am J Physiol Renal Physiol 282: F592-F598, 2002.
6. Ichiki T, Labosky PA, Shiota C, Okuyama S, Imagawa Y, Fogo A, Nimura F, Ichikawa I, Hogan BL, and Inagami T. Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature 377: 748-750, 1995.
7. Itoh H, Mukoyama M, Pratt RE, Gibbons GH, and Dzau VJ. Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II. J Clin Invest 91: 2268-2274, 1993.
8. Morishita R, Higaki J, Miyazaki M, and Ogihara T. Possible role of the vascular renin-angiotensin system in hypertension and vascular hypertrophy. Hypertension 19: II62-II67, 1992.
9. Mukoyama M, Nakajima M, Horiuchi M, Sasamura H, Pratt RE, and Dzau VJ. Expression cloning of type 2 angiotensin II receptor reveals a unique class of seven-transmembrane receptors. J Biol Chem 268: 24539-24542, 1993.
10. Munzenmaier DH and Greene AS. Opposing actions of angiotensin II on microvascular growth and arterial blood pressure. Hypertension 27: 760-765, 1996.
11. Sanchez PL, Salgado LM, Ferreri NR, and Escalante B. Effect of cyclooxygenase-2 inhibition on renal function after renal ablation. Hypertension 34: 848-853, 1999.
12. Shibata K, Makino I, Shibaguchi H, Niwa M, Katsuragi T, and Furukawa T. Upregulation of angiotensin type 2 receptor mRNA by angiotensin II in rat cortical cells. Biochem Biophys Res Commun 239: 633-637, 1997.
13. 2) angiotensin receptor mediates renal production of nitric oxide in conscious rats. J Clin Invest 100: 264-269, 1997.
14. 2 receptor in a renal wrap hypertension model. Hypertension 33: 1237-1242, 1999.
15. Siragy HM and Carey RM. Angiotensin type 2 receptors: potential importance in the regulation of blood pressure. Curr Opin Nephrol Hypertens 10: 99-103, 2001.
16. 2) angiotensin receptor. Proc Natl Acad Sci USA 96: 6506-6510, 1999.
17. Tamura M, Takagi T, Howard EF, Landon EJ, Steimle A, Tanner M, and Myers PR. Induction of angiotensin II subtype 2 receptor-mediated blood pressure regulation in synthetic diet-fed rats. J Hypertens 18: 1239-1246, 2000.
18. Tapia E, Franco M, Sánchez-Lozada LG, Soto V, Avila-Casado C, Santamaría J, Quiroz Y, Rodríguez-Uribe B, and Herrera-Acosta J. Mycophenolate mofetil prevents arteriolopathy and renal injury in subtotal ablation despite persistent hypertension. Kidney Int 63: 994-1002, 2003.
19. 2 receptors in angiotensin II-stimulated contraction of small mesenteric arteries in young SHR. Hypertension 33: 366-372, 1999.
20. Viswanathan M, Tsutsumi K, Correa FM, and Saavedra JM. Changes in expression of angiotensin receptor subtypes in the rat aorta during development. Biochem Biophys Res Commun 179: 1361-1367, 1991.
21. 2 receptor protein in rats with angiotensin-dependent hypertension. Hypertension 33: 96-101, 1999.
22. Wu JN, Edwards D, and Berecek KH. Changes in renal angiotensin II receptors in spontaneously hypertensive rats by early treatment with the angiotensin-converting enzyme inhibitor captopril. Hypertension 23: 819-822, 1994.